Literature DB >> 4358588

Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital.

D C Ihde, P Sherlock, S J Winawer, J G Fortner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4358588     DOI: 10.1016/0002-9343(74)90753-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  26 in total

1.  Metastasis in an axillary lymph node in hepatocellular carcinoma:a case report.

Authors:  Michael R Alison; Gladwyn Leiman; Michael C Kew
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 2.  [Carcinofetal antigens. I. alpha-fetoprotein (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-02-15

Review 3.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 4.  The role of cirrhosis in the etiology of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  J Gastrointest Cancer       Date:  2014-03

5.  Extrahepatic biliary tract obstruction secondary to a hepatoma-containing blood clot in the common bile duct.

Authors:  S N Brand; L J Brandt; S Sprayregan; S Brenner; L H Bernstein
Journal:  Am J Dig Dis       Date:  1976-10

Review 6.  Geographic heterogeneity of hepatocellular carcinoma.

Authors:  K Okuda
Journal:  Gastroenterol Jpn       Date:  1990-12

7.  Primary hepatocellular carcinoma--recent advances and future prospects.

Authors: 
Journal:  West J Med       Date:  1985-10

8.  Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves.

Authors:  Soo Ryang Kim; Fumio Kanda; Hiroshi Kobessho; Koji Sugimoto; Toshiyuki Matsuoka; Masatoshi Kudo; Yoshitake Hayashi
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

9.  Hepatic arterial embolization for malignant hypercalcemia in hepatocellular carcinoma.

Authors:  P Attali; D Houssin; A Roche; C Buffet; H Bismuth; J P Etienne
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

10.  Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma.

Authors:  J S Albaugh; E B Keeffe; W W Krippaehne
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.